Related Experiment Video
Updated: May 17, 2026

From a Natural Product to Its Biosynthetic Gene Cluster: A Demonstration Using Polyketomycin from Streptomyces diastatochromogenes Tü6028
Published on: January 13, 2017
The biosynthesis of caprazamycins and related liponucleoside antibiotics: new insights
Bertolt Gust1, Kornelia Eitel, Xiaoyu Tang
1Department of Pharmceutical Biology, Pharmaceutical Institute, Eberhard Karls University Tübingen, Auf der Morgenstelle 8, D-72076 Tübingen, Germany. bertolt.gust@uni-tuebingen.de
Abstract:
The first step in the membrane cycle of reactions during peptidoglycan biosynthesis is the transfer of phospho-MurNAc-pentapeptide from UDP-MurNAc-pentapeptide to undecaprenyl phosphate, catalyzed by the integral membrane protein MraY translocase. Different MraY inhibitors are known and can be subdivided into classes depending on their structural composition. Caprazamycins belong to the liponucleoside class of antibiotics isolated from Streptomyces sp. MK730-62F2. They possess activity in vitro against Gram-positive bacteria, in particular against the genus Mycobacterium including Mycobacterium intracellulare, Mycobacterium avium and Mycobacterium tuberculosis. Caprazamycins and the structurally related liposidomycins and A-90289 share a unique composition of moieties. Their complex structure is derived from 5'-(β-O-aminoribosyl)-glycyluridine and comprises a unique N,N'-dimethyldiazepanone ring. Recently, the corresponding biosynthetic gene clusters of caprazamycins, liposidomycins and A-90289 have been discovered and will be compared in this review. New information is also emerging regarding the biosynthesis of liponucleoside antibiotics obtained by gene disruption experiments and biochemical investigations.
Insights
Caprazamycins are liponucleoside antibiotics effective against Mycobacterium species. This review compares their biosynthetic gene clusters and explores their complex structures and origins.
Area of Science:
- Microbiology
- Biochemistry
- Synthetic Biology
Background:
- Peptidoglycan biosynthesis is essential for bacterial cell walls, with MraY translocase catalyzing a key early step.
- MraY inhibitors, including liponucleosides like caprazamycins, offer potential antibacterial strategies.
- Caprazamycins exhibit in vitro activity against Gram-positive bacteria, notably Mycobacterium species.
Purpose of the Study:
- To review and compare the biosynthetic gene clusters of caprazamycins, liposidomycins, and A-90289.
- To explore the complex structures and origins of these liponucleoside antibiotics.
- To present emerging information on liponucleoside antibiotic biosynthesis.
Main Methods:
- Comparative analysis of recently discovered biosynthetic gene clusters.
- Review of structural composition of caprazamycins, liposidomycins, and A-90289.
- Integration of data from gene disruption experiments and biochemical investigations.
Main Results:
- Caprazamycins, liposidomycins, and A-90289 share unique structural moieties derived from 5'-(β-O-aminoribosyl)-glycyluridine.
- The N,N'-dimethyldiazepanone ring is a characteristic feature of these compounds.
- Discovery and comparison of the corresponding biosynthetic gene clusters provide insights into their production.
Conclusions:
- Understanding the biosynthesis of liponucleoside antibiotics is crucial for developing new antibacterial agents.
- Comparative genomics of biosynthetic gene clusters aids in elucidating antibiotic production pathways.
- Further research into gene disruption and biochemical studies will refine our knowledge of liponucleoside antibiotic synthesis.
Related Concept Videos
Inhibitors of Gram-positive Cell Wall Synthesis
Biosynthesis of Nucleic Acids
Biosynthesis of Lipids
Biosynthesis in Bacteria
Production of Antibiotics
Inhibitors of Bacterial Protein Synthesis
